Walmart settles US government opioid lawsuit for $50 million

Walmart has agreed to pay $50 million to settle a 2020 U.S. Justice Department lawsuit accusing the retailer of fueling the nationwide opioid epidemic by failing to detect and report suspicious prescriptions. Walmart did not admit liability, calling the payout immaterial relative to its $11.7 billion half-year net income. The settlement, which is far lower than the billions initially sought, requires Walmart to implement tighter pharmacy oversight, including a reporting hotline.

Walmart opioid settlement

• ▪A joint stipulation dismissing the federal lawsuit against Walmart was filed on August 27, 2026, in the federal court in Wilmington, Delaware.
• ▪Walmart settled a United States government lawsuit on August 28, 2026, which accused the retailer of fueling the nationwide opioid epidemic through its pharmacies.
• ▪Walmart previously agreed in 2022 to pay $3.1 billion to settle thousands of opioid-related lawsuits brought by state, local, and tribal governments.
• ▪Walmart did not admit liability in the federal settlement, stating in a regulatory filing that the company was pleased to resolve the matter.

Controlled Substances Act violations

• ▪Judge Colm Connolly allowed the U.S. government to pursue claims that Walmart pharmacists dispensed prescriptions they or compliance personnel knew were invalid.
• ▪In March 2024, U.S. District Judge Colm Connolly narrowed the lawsuit against Walmart, dismissing claims that the company failed to report suspicious prescriptions to the Drug Enforcement Administration.
• ▪The federal lawsuit alleged Walmart pharmacists filled prescriptions for excessively large doses and ignored warnings about a Florida doctor suspected of running a "pill mill."
• ▪The U.S. Justice Department's 2020 lawsuit alleged Walmart violated the Controlled Substances Act since 2013 by failing to detect and report suspicious opioid prescriptions.

Fifty million dollar payment

• ▪Walmart characterized the $50 million settlement payout as "immaterial" relative to its net income, which totaled $11.7 billion for the six months ending July 31, 2026.
• ▪The $50 million settlement is significantly less than the billions of dollars in civil penalties the U.S. government initially sought when filing the lawsuit in December 2020.
• ▪The settlement requires Walmart to establish an employee and patient hotline to report suspected illegal dispensing and to monitor pharmacy dispensing patterns.
• ▪Under the settlement announced on August 28, 2026, Walmart will pay $50 million to resolve the federal government's opioid lawsuit.

Justice Department enforcement actions

• ▪The Justice Department has targeted other companies over the opioid epidemic, including Purdue Pharma, which pleaded guilty to criminal charges in 2020, and Cencora.
• ▪The lawsuit against Walmart was one of the Justice Department's most significant civil actions targeting a single company over its role in the opioid epidemic.
• ▪Kroger agreed in 2023 to pay $1.2 billion to settle claims that its retail pharmacies improperly monitored opioid prescriptions and fueled the crisis.

Opioid epidemic deaths

• ▪Approximately 806,000 people in the United States died from opioid overdoses, including prescription and illegal opioids, between 1999 and 2023, according to the Centers for Disease Control and Prevention.
• ▪More than 905,000 people in the United States died from opioid overdoses between 1999 and 2025, with annual deaths beginning to decline after 2022, according to the Centers for Disease Control and Prevention.

4 sources